Clinical Trials on HER2 Positive Breast in Germany

Total 900 results

German Breast Group
Celgene; Amgen

Completed

Study of Nab-Paclitaxel in High Risk Early Breast Cancer (GAIN-2)

Breast Cancer

Germany
West German Study Group
Sanofi; Roche Pharma AG

Terminated

Imaging for Response Assessment of Neoadjuvant Chemotherapy in Primary Breast Cancer (GALADON)

Breast Cancer

Germany
NanoString Technologies, Inc.

Completed

A Prospective Observational Study of Clinical Outcomes for the NanoString® Technologies Prosigna™ Gene Signature Assay

Breast Cancer

Germany
German Breast Group
AGO Study Group

Completed

Taxol Epirubicin Cyclophosphamide Herceptin Neoadjuvant (TECHNO)

Breast Cancer

Germany
Heidelberg University
DLR German Aerospace Center

Unknown

Adjuvant Whole Breast Radiotherapy (RT) With Intensity Modulated Radiotherapy (IMRT) and a Simultaneous Integrated Boost Versus Conventional RT and a Sequential Boost (IMRT-MC2)

Breast Cancer

Germany
University Hospital Erlangen

Unknown

Dose Optimization for Pulsed-dose-rate (PDR)/High-dose-rate (HDR) Brachytherapy Alone for Early Breast Cancer

Breast Cancer

Germany
Institut für Klinische Krebsforschung IKF GmbH...
Medizinische Hochschule Hannover, Germany, Prof. Dr. Arndt Vogel; MSD Sharp...

Recruiting

Efficacy and Safety of GemCis Plus Trastuzumab Plus Pembrolizumab in Previously Untreated HER2-positive Biliary Tract Cancer (TRAP-BTC)

Biliary Tract Cancer | HER2 Gene Mutation

Germany
Palleos Healthcare GmbH
Pfizer; Cankado GmbH; WSG WOMEN´S HEALTHCARE STUDY GROUP; AGO-TraFo; AGO-B; Deutsche...

Terminated

Impact of eHealth-support on Quality of Life in Metastatic Breast Cancer Patients Treated With Palbociclib and Endocrine Therapy (PRECYCLE)

Breast Neoplasm

Germany
German Cancer Research Center
University Hospital Heidelberg; National Center for Tumor Diseases, Heidelberg

Completed

Effects of a Supervised Progressive Resistance Training With Breast Cancer Patients During Adjuvant Radiotherapy (BEST)

Breast Cancer | Cancer-related Fatigue

Germany
iOMEDICO AG

Completed

Non-interventional Study With Nab-Paclitaxel (Abraxane®) (NABUCCO)

Metastatic Breast Cancer

Germany
Novartis

Terminated

Safety/Efficacy of Intravenous Zoledronic Acid When Added to Standard Therapies in Patients With Breast Cancer and Metastatic Bone Lesions

Breast Cancer With Bone Metastasis

Germany
Heidelberg University
Verein für Krebsforschung, Arlesheim, Swizzerland; Weleda AG, D-73525 Schwäbisch...

Completed

Mistletoe Extract in Early or Advanced Breast Cancer, A Feasibility Study

Metastatic Breast Cancer

Germany
German Breast Group
Goethe University

Recruiting

Breast Cancer in Pregnancy Register Study (BCP)

Breast Cancer

Germany
University Hospital, Essen
Novartis Pharmaceuticals; iOMEDICO AG

Completed

Trial of BKM120/Tamoxifen-combination in Patients With HR-pos, HER2-neg Breast Cancer (PIKTAM)

Breast Cancer

Germany
German Breast Group
Hoffmann-La Roche; AstraZeneca

Completed

Study in Elderly Patients With Early Breast Cancer (ICE)

Breast Cancer

Germany
West German Study Group
Roche Pharma AG

Active, not recruiting

A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Trastuzumab Emtansine (T-DM1) With or Without Standard Endocrine Therapy vs. Trastuzumab With Standard Endocrine Therapy Given for Twelve Weeks in Patients With Operable HER2+/HR+ Breast Cancer Within the ADAPT Protocol. (ADAPT; T-DM1)

Breast Cancer

Germany
BioNTech SE
Seventh Framework Programme

Completed

RNA-Immunotherapy of IVAC_W_bre1_uID and IVAC_M_uID (TNBC-MERIT)

Breast Cancer (Triple Negative Breast Cancer (TNBC))

Sweden, Germany
University Women's Hospital Tübingen

Completed

14 g vs. 16 g in Breast Biopsy

Breast Biopsy

Germany
University Women's Hospital Tübingen

Completed

Conserving Breast Surgery - Comparison of Conventional With Sonography (MAC-001)

Breast Surgery

Germany
German Breast Group

Completed

Combination Chemotherapy With or Without Capecitabine and/or Trastuzumab Before Surgery in Treating Women With Stage I, Stage II, or Stage III Breast Cancer

Breast Cancer

Germany
University Hospital Tuebingen

Recruiting

Postoperative Pain After Breast Surgery Under Tumescent Local Anaesthesia Versus General Anaesthesia ( TLA-001 )

Breast Carcinoma | Breast Carcinoma in Situ

Germany
Kliniken Essen-Mitte
German Breast Group

Completed

Registry Trial to Evaluate the Clinical Utilization of Targeted Axillary Dissection (TAD)

Early Stage Breast Cancer

Germany
Charite University, Berlin, Germany
Mammazentrum Hamburg am Krankenhaus Jerusalem, Germany; Dorit und Alexander...

Completed

Evaluation of Effectiveness of Acupuncture on Quality of Life in Patients With Breast Cancer Receiving Chemotherapy

Breast Cancer

Germany
International Research Training Group 2804
German Research Foundation; Uppsala University; University Hospital Tuebingen

Not yet recruiting

Breast Cancer & Antiestrogenic Therapy & Brain

Menopause | Breast Cancer Female | Healthy Female | Anti-estrogenic Therapy

Germany
German Breast Group

Completed

Adjuvant Chemotherapy for Elderly Non Frail Patients With an Increased Risk for Relapse of a Primary Carcinoma of the Breast (ICE-II)

Breast Cancer

Germany
Helios University Hospital Wuppertal
Medical University of Graz; Oslo University Hospital; Jagiellonian University; University... and other collaborators

Completed

Psychometric Properties of the Updated Module on Assessing Quality of Life of Patients With Breast Cancer (EORTCQLQBR45)

Quality of Life | Breast Cancer

Germany
German Breast Group

Completed

Prevention of Chemotherapy Induced Ovarian Failure With Goserelin in BC Patients (ZORO)

Breast Cancer

Germany
Heidelberg University
Hector-Stiftung; Schwabe-Wenex International Ltd; Cefak KG, Kempten; Ursapharm,...

Completed

Complementary Therapies for the Reduction of Side Effects During Chemotherapy for Breast Cancer

Breast Cancer

Germany
Technical University of Dortmund
University of Leipzig; Gaia AG

Terminated

Evaluating a Novel Web-based Intervention for Breast Cancer Survivors (OPTIMUNE)

Breast Cancer

Germany
German Breast Group

Terminated

A Randomized Study to Determine the Efficacy of a Taxane and Bevacizumab With or Without Capecitabine as First Line Chemotherapy in Patients With Metastatic Breast Cancer (TABEA)

Breast Cancer

Germany
German Cancer Research Center
University Hospital Heidelberg

Active, not recruiting

Exercise Interventions for Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy (BENEFIT)

Breast Cancer

Germany
Hoffmann-La Roche

Completed

A Study of Trastuzumab Subcutaneous in Participants With Human Epidermal Growth Factor Receptor-2 (HER2) Positive Early Breast Cancer (HerSCin)

Breast Neoplasms

Germany
University Hospital Tuebingen

Recruiting

Prolactin Release Through Breast Stimulation in Non-lactating Women - Who Does Respond?

Prolactin | Breast Stimulation

Germany
German Cancer Research Center
University Hospital Heidelberg

Recruiting

CATCH: Implementation of Genomics-guided Precision Medicine in Metastatic Breast Cancer (CATCH)

Metastatic Breast Cancer

Germany
Klinikum Weissenfels

Completed

Neoadjuvant Chemotherapy of Primary Breast Cancer With Epirubicin/Docetaxel and Carboplatin/Docetaxel (ETCat01)

Primary Breast Cancer

Germany
Novartis Pharmaceuticals

Terminated

Zoledronic Acid in the Treatment of Breast Cancer With Minimal Residual Disease in the Bone Marrow (MRD-1)

Primary Breast Cancer

Germany
Eli Lilly and Company

Completed

Combination Chemotherapy for Metastatic Breast Cancer

Breast Cancer

Germany, Russian Federation
University Hospital Schleswig-Holstein
Zealand University Hospital

Not yet recruiting

Sleep Disorders Prior to and During a Course of Radiotherapy for Breast Cancer (RADIO-SLEEP)

Breast Cancer Female

Germany
Pantarhei Oncology B.V.

Completed

Assessment of Safety and Efficacy of Estetrol in Postmenopausal Women With Advanced Estrogen Receptor Positive (ER+) Breast Cancer

Breast Neoplasms

Germany
Universität Duisburg-Essen
Karl and Veronica Carstens Foundation

Completed

Effectiveness of Ear Acupuncture to Improve Insomnia in Women With Breast Cancer (EOMI)

Breast Neoplasm

Germany
Universität Duisburg-Essen

Completed

Preoperative Relaxation Training and Acupuncture to Minimize Perioperative Symptoms in Breast Cancer Patients

Breast Neoplasms

Germany
Technische Universität Dresden
Radboud University Medical Center; UMC Utrecht; Cambridge University Hospitals... and other collaborators

Active, not recruiting

A Retrospective Analysis of Magnetic Resonance Imaging Data for Breast Cancer Screening in the Open Consortium for Decentralized Medical Artificial Intelligence (ODELIA)

Breast Cancer

Germany
Tumor Center Regensburg
German Cancer Aid

Completed

Long-term Improvement of Quality of Life in Breast Cancer Patients With Quality of Life Diagnosis and Therapy

Quality of Life | Breast Cancer | Breast Neoplasms

Germany
Institut fuer Frauengesundheit
Novartis; ClinSol

Unknown

Evaluation of Predictive Factors Regarding the Effectivity of Aromatase Inhibitor Therapy (PreFace) (PreFace)

is to Identify Biomarkers That Could Predict the Efficacy of an Adjuvant Letrozol Treatment in Postmenopausal Breast Cancer Patients.

Germany
West German Study Group

Active, not recruiting

Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer (ADAPT)

Breast Cancer

Germany
West German Study Group

Active, not recruiting

ADAPT - Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer (ADAPT)

Breast Cancer

Germany
German Breast Group
Hoffmann-La Roche

Completed

Mono Efficacy of Capecitabine (MoniCa)

Breast Cancer

Germany
German Cancer Research Center
German Federal Ministry of Education and Research; University Hospital Heidelberg

Recruiting

COGNITION: Genomics-Guided Precision Oncology in Early High-Risk Breast Cancer (COGNITION)

Neoadjuvant Therapy | Early-Stage Breast Cancer

Germany
German Breast Group
Hoffmann-La Roche

Completed

TBP Study With Capecitabine Plus Minus Trastuzumab

Breast Cancer

Germany
University Hospital Tuebingen

Recruiting

Trial Evaluating the Benefit of a Fitness Tracker Based Workout During Adjuvant Radiotherapy of Breast Cancer (OnkoFit I)

Breast Cancer

Germany

3

Subscribe